# Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease

> **NCT05209100** · — · COMPLETED · sponsor: **AdventHealth Translational Research Institute** · enrollment: 38 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **PROCEDURE:** Sigmoidoscopy

## Key facts

- **NCT ID:** NCT05209100
- **Lead sponsor:** AdventHealth Translational Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-11
- **Primary completion:** 2023-03-22
- **Final completion:** 2023-03-22
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05209100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05209100, "Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05209100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*